Institutional investors purchased a net $5.1 million shares of NEO during the quarter ended March 2013. This may signal that the smart money is gaining interest in this company as the 27.10% of shares outstanding that institutional investors hold is actually below the Medical/Nursing Services industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 1.0 Million shares of Neogenomics Inc